Detroit could become one of the next Michigan cities to decriminalize psychedelics, with the reform proposal making the local ballot for this November.
Exploring the companies and themes that make up this emerging and exciting new sector
Why Psychedelic Medicine Cures Will Have Greater Profit Potential Than Big Pharma Bandaids
Big Pharma's business model for drug development is all about maximizing profits, not health. Psychedelic medicine can maximize profits AND health.
Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds
Psychedelics media star, Hamilton Morris is joining Compass Pathways as a full-time consultant on psychedelics research.
Psychedelic Stocks Chasing Medical Treatment Markets With Combined Value Of $330B
Two BILLION people with untreated mental health disorders is a lot of market potential. We attach some numbers to these treatment markets.
Wesana Health Announces Closing of PsyTech Acquisition
Wesana Health closes on its acquisition of PsyTech, solidifying its business model as it seeks a U.S. listing.
Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1
Psyched Wellness moves a step closer to commencing its Phase I clinical trial on AME-1. The company is still targeting commercialization for 2022.
Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering with Leading Canadian Fresh and Dried Mushroom Producers on East Coast Facility
Red Light Holland closes on its majority ownership in Acadian Exotic Mushrooms, now holding a 51% interest.
The Economics of Psychedelics
Roughly 8 million people per year are dying preventable deaths because of lack of (legal) access to psychedelic medicine. It's also killing the economy.
Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial
Mydecine and Johns Hopkins plan a "seamless" (combined) Phase II/III clinical trial of MYCO-001 to treat nicotine addiction.
Oregon Psilocybin Panel Teams Up With Harvard To Research Psychedelic History And Impacts Of Reform
An Oregon state panel charged with advising on the implementation of a legal psilocybin therapy program has cleared a team of researchers to produce a comprehensive report on the science, history and culture of the psychedelic as regulators prepare to license facilities to administer it.
Washington Officials Join Cancer Patients In Federal Court Argument Pushing DEA To Allow Psilocybin Access
The Washington State attorney general’s office appeared alongside lawyers representing cancer patients on Thursday, telling a federal appeals panel that people in end-of-life care deserve legal access to psilocybin under state and federal right-to-try laws.
The DEA Proves It Must Be Immediately Abolished
The DEA fights to keep psychedelic drugs illegal while it admits these drugs have valuable medical uses. Meanwhile, Americans are dying every day from lack of legal access.